Meridian Bioscience Receives FDA Clearance for New Molecular Amplification Test: illumigene® Pertussis

March 27, 2014 Meridian Bioscience, Inc., Cincinnati, Ohio today announced that it has received FDA clearance for a new molecular diagnostic test for Bordetella pertussis (B. pertussis), its fifth assay on the illumigene platform. This innovative test is the first FDA-cleared molecular stand-alone assay for B. pertussis providing a solution to the unmet need of today’s healthcare market. Often referred to as “whooping cough”, Bordetella pertussis can cause serious illness in infants, …